AstraZeneca-backed Evinova integrates three-in-one Lothar Medical lung testing into global trial platform
Evinova and Lothar Medical will integrate a three-in-one pulmonary assessment device with a clinical-trial platform already used at more than 4,000 sites in 54 countries.